Security Snapshot

DBV Technologies S.A. - Ordinary Shares, nominal value 0.10 euro per share (DBVT) Institutional Ownership

CUSIP: 23306J309

13F Institutional Holders and Ownership History from Q4 2024 to Q1 2026

Latest Period

Q1 2026

Institutions Reporting

70

Shares (Excl. Options)

20,652,141

Price

$20.89

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Latest holder snapshot 5 signals
Portfolio coverage rank
0%
Share change
+5,001,045
Value change
+$106,597,385
Number of holders
70
Issuer context Names, identifiers, and filing context for this profile. 3 identity fields
Shares outstanding
296,213,705
SEC-reported price per share
$19.60
Insider filing price
$19.60
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors

Key facts

  • DBVT - DBV Technologies S.A. - Ordinary Shares, nominal value 0.10 euro per share is tracked under CUSIP 23306J309.
  • 70 institutions reported positions in Q1 2026.
  • 10 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 51 to 70 between Q4 2025 and Q1 2026.
  • SEC-reported value moved from $300,031,912 to $431,385,223.

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 70 institutions filings for Q1 2026.

Open SEC evidence

Security key

23306J309

Latest holder period

Q1 2026

13F holders

70

13D/G owners

10

CIK / CUSIP context first

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
10
Security
DBVT
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
MPM BioImpact LLC 8.8% -11% $577,119,085 +$32,933,228 26,066,806 +6.1% MPM BioImpact LLC 31 Mar 2026
BAKER BROS. ADVISORS LP 10% -42% $490,489,821 +$40,190,632 25,586,190 +8.9% Baker Bros. Advisors LP 12 Jan 2026
Adage Capital Management, L.P. 7.3% -27% $493,121,652 +$169,557,751 22,272,884 +52% Adage Capital Management, L.P. 31 Mar 2026
Invus Global Management, LLC 6.5% +5% $427,523,511 +$109,793,256 19,310,005 +35% Raymond Debbane 31 Mar 2026
Vivo Opportunity Fund Holdings, L.P. 5.7% -43% $281,249,084 -$83,778,284 15,685,950 -23% Vivo Opportunity Fund Holdings, L.P. 12 Jan 2026
SUVRETTA CAPITAL MANAGEMENT, LLC 9.9% $129,451,408 15,176,015 SUVRETTA CAPITAL MANAGEMENT, LLC 07 Apr 2025
Bpifrance Participations SA 4.7% -12% $208,927,156 -$1,663,524 10,898,595 -0.79% Caisse des Depots 05 Jan 2026
CITADEL ADVISORS LLC 6.4% $78,425,733 9,194,107 Kenneth Griffin 07 Apr 2025
Artisan Partners Limited Partnership 7% $63,484,551 3,309,055 Artisan Partners Asset Management Inc. 31 Dec 2025
BRAIDWELL LP 2.5% $20,419,242 2,393,815 BRAIDWELL LP 31 Dec 2024

As of 31 Mar 2026, 70 institutional investors reported holding 20,652,141 shares of DBV Technologies S.A. - Ordinary Shares, nominal value 0.10 euro per share (DBVT). This represents 7% of the company’s total 296,213,705 outstanding shares.

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
6
Latest
Q1 2026
Rows shown
1-6 of 6
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q1 20,652,141 $431,385,223 +$106,597,385 $20.89 70
2025 Q4 15,651,096 $300,031,912 +$177,608,887 $19.17 51
2025 Q3 6,519,288 $65,192,849 -$7,091,842 $10.00 33
2025 Q2 7,232,641 $66,227,520 +$43,932,994 $9.16 29
2025 Q1 2,467,870 $16,830,914 -$450,513 $6.82 16
2024 Q4 2,737,085 $8,457,814 +$8,298,133 $3.09 18
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .